Related references
Note: Only part of the references are listed.Cell line-directed breast cancer research based on glucose metabolism status
Pegah Farhadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Sigma-1 Receptor Modulation by Ligands Coordinates Cancer Cell Energy Metabolism
Furkan E. Oflaz et al.
BIOMOLECULES (2022)
Sigma-1 Receptor Is Critical for Mitochondrial Activity and Unfolded Protein Response in Larval Zebrafish
Lucie Crouzier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
Sindhu Govindan et al.
BMC CANCER (2020)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 30, pg 128, 2019)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Pharmacological targeting of the unfolded protein response for disease intervention
Claudio Hetz et al.
NATURE CHEMICAL BIOLOGY (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes
Halley M. Oyer et al.
FRONTIERS IN PHARMACOLOGY (2019)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Ajuba receptor mediates the internalization of tumor-secreted GRP78 into macrophages through different endocytosis pathways
Xiaoqin La et al.
Oncotarget (2018)
The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca2+ homeostasis
M. Gueguinou et al.
ONCOGENE (2017)
Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells
Rui Li et al.
ONCOTARGET (2017)
The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins
Alice Dreser et al.
CELL DEATH AND DIFFERENTIATION (2017)
Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer
Jeffrey D. Thomas et al.
CANCER RESEARCH (2017)
S100β as a serum marker in endocrine resistant breast cancer
Sara Charmsaz et al.
BMC MEDICINE (2017)
The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems
Tsung-Ping Su et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
NF-kappa B Signaling Is Required for XBP1 (Unspliced and Spliced)-Mediated Effects on Antiestrogen Responsiveness and Cell Fate Decisions in Breast Cancer
Rong Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
Xi Chen et al.
NATURE (2014)
Sigma-1 Receptor Chaperone at the ER-Mitochondrion Interface Mediates the Mitochondrion-ER-Nucleus Signaling for Cellular Survival
Tomohisa Mori et al.
PLOS ONE (2013)
Sequential Cytoprotective Responses to Sigma1 Ligand-Induced Endoplasmic Reticulum Stresss
Joel M. Schrock et al.
MOLECULAR PHARMACOLOGY (2013)
Endoplasmic Reticulum Stress, the Unfolded Protein Response, Autophagy, and the Integrated Regulation of Breast Cancer Cell Fate
Robert Clarke et al.
CANCER RESEARCH (2012)
Overexpression of Sigma1 Receptor and Its Positive Associations With Pathologic TNM Classification in Esophageal Squamous Cell Carcinoma
Qing-Xia Xu et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
K. Albain et al.
LANCET (2012)
Clinical relevance of TNM staging system according to breast cancer subtypes
Y. H. Park et al.
ANNALS OF ONCOLOGY (2011)
GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy
Eunjung Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade
Britta Weigelt et al.
JOURNAL OF PATHOLOGY (2010)
Breast cancer prognostic classification in the molecular era: the role of histological grade
Emad A. Rakha et al.
BREAST CANCER RESEARCH (2010)
Expression and splicing of the unfolded protein response gene XBP-1 are sieniticantly associated with clinical outcome of endocrine-treated breast cancer
Michael P. A. Davies et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival
Teruo Hayashi et al.
CELL (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
Kenneth R. Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer
Eunfung Lee et al.
CANCER RESEARCH (2006)
Stressing out the EIR: A role of the unfolded protein response in prion-related disorders
CA Hetz et al.
CURRENT MOLECULAR MEDICINE (2006)
Small molecule antagonists of the σ-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo
BA Spruce et al.
CANCER RESEARCH (2004)
Expression of sigma 1 receptor in human breast cancer
B Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
